Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 136

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 136
---
 2025 |
| Olivier Samuel                    |     |                                                     |     |                   |

<div align='center'>II-6

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the Securities Act of 1933, as amended,
the undersigned, Puglisi & Associates, the duly authorized representative in the United States of NLS Pharmaceutics Ltd., has signed
this registration statement on February 10, 2025.

| Puglisi & Associates |                       |
| By:                  | /s/ Donald J. Puglisi |
| Name:                | Donald J. Puglisi     |
| Title:               | Managing Director     |

<div align='center'>II-7</div>